abstract |
The use of 1- (2-naphthyl-2-ylethyl) -4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine or its addition salts with pharmaceutically acceptable acids for the manufacture of medicaments for the treatment of amyotrophic lateral sclerosis (ALS) .à |